James Foster, Charles River Laboratories CEO, offers insight on his company's quarterly earnings, and how the drug approval process fits in with the FDA's work.
Data is a real-time snapshot *Data is delayed at least 15 minutes Market Data Terms of Service
Global Business and Financial News, Stock Quotes, and Market Data and Analysis
More Comments
ADD COMMENTS
PREVIEW COMMENT